Zobrazeno 1 - 10
of 298
pro vyhledávání: ''
Publikováno v:
PLoS Medicine, Vol 18, Iss 9, p e1003702 (2021)
PLoS Medicine
PLoS Medicine
Background Tuberculosis preventive therapy (TPT) reduces TB-related morbidity and mortality in people living with HIV (PLHIV). Cascade-of-care analyses help identify gaps and barriers in care and develop targeted solutions. A previous latent tubercul
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 15, Iss 7, p e0009602 (2021)
PLoS Neglected Tropical Diseases
PLoS Neglected Tropical Diseases
Chagas disease (CD) is a human disease caused by Trypanosoma cruzi. Whilst endemic in Latin America, the disease is spread around the world due to migration flows, being estimated that 8 million people are infected worldwide and over 10,000 people di
Publikováno v:
PLoS ONE, Vol 16, Iss 10 (2021)
PLoS ONE
PLoS ONE, Vol 16, Iss 10, p e0259221 (2021)
PLoS ONE
PLoS ONE, Vol 16, Iss 10, p e0259221 (2021)
Multidrug-resistant tuberculosis (MDR-TB) has become a major threat to the control of tuberculosis globally. Uganda is among the countries with a relatively high prevalence of tuberculosis despite significant control efforts. In this study, the drug
Autor:
Han-Jung Chae, Myong-Ja Chung, Jong-Sik Jin, In-Yeong Kang, Hwa-Young Lee, Seon-Ah Park, Geum-Hwa Lee, The-Hiep Hoang
Publikováno v:
PLoS ONE, Vol 16, Iss 4, p e0250354 (2021)
PLoS ONE
PLoS ONE
Constipation is a common condition that affects individuals of all ages, and prolonged constipation needs to be prevented to avoid potential complications and reduce the additional stress on individuals with pre-medical conditions. This study aimed t
Autor:
Delfina Fernandes Hlashwayo, Betuel Sigaúque, Sónia Afonso, Custódio Gabriel Bila, Inacio Mandomando, Emilia Virginia Noormahomed
Publikováno v:
PLoS ONE, Vol 16, Iss 1, p e0245951 (2021)
PLoS ONE
PLoS ONE
Introduction Campylobacter spp. are zoonotic bacteria that cause gastroenteritis in humans worldwide, whose main symptom is diarrhea. In certain cases, extra intestinal manifestations may occur, such as Guillain Barré syndrome. The bacteria cause se
Autor:
Dakai Liu, Vincent Gau, Amorina Cruz, Jade Chen, Michael Tomasek, William H. Rodgers, Matthew L. Faron
Publikováno v:
PLoS ONE, Vol 16, Iss 3, p e0249203 (2021)
PLoS ONE
PLoS ONE
The emergence and evolution of antibiotic resistance has been accelerated due to the widespread use of antibiotics and a lack of timely diagnostic tests that guide therapeutic treatment with adequate sensitivity, specificity, and antimicrobial suscep
Publikováno v:
PLoS ONE, Vol 16, Iss 4, p e0250896 (2021)
PLoS ONE
PLoS ONE
Background Acinetobacter species have been a leading cause of nosocomial infections, causing significant morbidity and mortality over the entire world including Ethiopia. The most important features of A. baumannii are its ability to persist in the h
Autor:
Filippo Andreetta, Livia Ferrari, Maria Elisa Perico, Rossella Defazio, Daniela Sabatini, Gabriella Bergamini, Stefano Di Palma, Antonio Felici
Publikováno v:
PLoS ONE, Vol 16, Iss 12, p e0260627 (2021)
PLoS ONE
PLoS ONE
Infectious pneumonia induced by multidrug resistant (MDR)Acinetobacter baumanniistrains is among the most common and deadly forms of healthcare acquired infections. Over the years, different strategies have been put in place to increase host suscepti
Publikováno v:
PLoS ONE, Vol 16, Iss 3, p e0248584 (2021)
PLoS ONE
PLoS ONE
A treatment option for constipation that improves the quality of life is needed since available laxatives do not effectively improve the quality of life in patients with constipation. A significant association between gut dysbiosis and constipation i
Autor:
Sonia Mara Raboni, Gislene Maria Botão Kussen, Libera Maria Dalla Costa, Ana Paula de Oliveira Tomaz, Keite da Silva Nogueira, Clea E Ribeiro
Publikováno v:
PLoS ONE, Vol 16, Iss 3, p e0247185 (2021)
PLoS ONE
PLoS ONE
Xpert® MTB/RIF has been widely used for tuberculosis (TB) diagnosis in Brazil, since 2014. This prospective observational study aimed to evaluate the performance of Xpert in different contexts during a two-year period: (i) laboratory and clinical/ep